サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：カルボプロストトロメタミン市場：製品剤形別、用途別、流通経路別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1351422

カルボプロストトロメタミン市場：製品剤形別、用途別、流通経路別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Carboprost Tromethamine Market, By Product Formulation, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 277 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
カルボプロストトロメタミン市場：製品剤形別、用途別、流通経路別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年08月01日
発行: AnalystView Market Insights
ページ情報: 英文 277 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

Carboprost tromethamineの市場規模は2022年に15億960万米ドルとなり、2023年から2030年にかけてCAGR 4.3%で拡大

カルボプロストトロメタミン市場- 市場力学：

  • 産後出血の有病率の増加、政府の取り組み、ヘルスケア政策が市場成長を牽引
  • 産後出血とは、出産後の過剰な出血のことで、世界的に妊産婦の罹患率と死亡率の主な原因となっています。産後出血（PPH）の有病率の増加により、カルボプロスト・トロメタミンのような産後出血のコントロールと管理に役立つ薬剤の需要が増加しています。さらに、出生率が高いため、産後出血の症例も増加しています。したがって、PPHの有病率の上昇は、世界のカルボプロスト・トロメタミン市場の成長を後押しすると思われます。しかし、高度に熟練したヘルスケア専門家の不足が、市場の需要を妨げる要因となっています。さらに、ヘルスケアや政府機関は、妊産婦ヘルスケアを改善し、妊産婦死亡率を最小限に抑えるためのいくつかのイニシアチブを可能にしています。これに伴い、産後出血を効果的に管理することに重点を置いたプログラムが実施されています。その結果、こうした取り組みがカルボプロスト・トロメタミンなどの医薬品需要を増加させ、カルボプロスト・トロメタミン市場の成長を促進することになります。

カルボプロストトロメタミン市場-セグメンテーション分析：

  • カルボプロストトロメサミンの世界市場は、製品の剤形、用途、流通チャネル、地域に基づいてセグメント化されます。
  • 製品は妊娠中絶薬と分娩後出血治療薬に分類されます。分娩後出血治療セグメントは優位性を維持すると思われます。このセグメントの成長は、産後出血（PPH）の有病率の増加に起因しています。出産件数の増加により、産後出血の発生率も上昇しています。
  • 市場は用途によって再構成用粉末製剤と注射用製剤の2つに分類されます。注射用製剤分野は、市場の急速な成長が見込まれます。注射剤は、投与量の制御や作用発現の速さなどの理由から、臨床現場で一般的に使用されています。さらに、注射剤は、効果的かつ迅速な治療が不可欠な分娩後出血のような緊急時に採用されることが多いです。
  • 市場は流通チャネルによって、オンライン薬局、病院薬局、小売薬局の3つに分類されます。予測期間中、最も大きな収益シェアを占めるのは病院薬局です。病院薬局は、カルボプロスト・トロメタミンのような医薬品にとって不可欠な流通チャネルです。また、病院薬局は、特に産後出血やこの薬剤の使用を必要とするさまざまな医療問題の場合に、必要に応じて調剤し、在庫する可能性が高いです。

カルボプロスト・トロメタミン市場-地理的洞察

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

カルボプロストトロメタミン市場-競合情勢：

分娩後出血を管理するための医療技術やテクノロジー技術の進歩は、カルボプロスト・トロメタミンなどの医薬品市場に影響を与えると予想されます。また、市場の成長は、同様の適応症に対する他の治療法や薬剤の影響を受ける可能性もあります。さらに、主要企業は提携、研究開発活動、M&A、パートナーシップなどの戦略を採用しています。例えば、2022年2月、Amnealは4つのジェネリック注射剤が承認されたと発表しました。さらに、アザシチジン100mg、アトロピン硫酸塩注射液USP 0.5mg/5 mL、カルボプロストトロメタミン注射液USP 250 mcg/mL、デキサメタゾンリン酸ナトリウム注射液USP 10 mg/mLは、米国食品医薬品局（FDA）から簡略新薬承認申請（ANDA）を取得しています。

目次

第1章 カルボプロストトロメタミン市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 カルボプロストトロメタミンの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 カルボプロストトロメタミン産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 カルボプロストトロメタミン市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 カルボプロストトロメタミン市場情勢

  • カルボプロストトロメタミン市場シェア分析、2022
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 カルボプロストトロメタミン市場- 製品処方別

  • 概要
    • 製品配合別セグメントシェア分析
    • 妊娠中絶
    • 産後出血の治療

第8章 カルボプロストトロメタミン市場- アプリケーション別

  • 概要
    • アプリケーション別のセグメントシェア分析
    • 戻し用粉末
    • 注射用製剤

第9章 カルボプロストトロメタミン市場- 流通チャネル別

  • 概要
    • 販売チャネル別のセグメントシェア分析
    • オンライン薬局
    • 病院薬局
    • 小売薬局

第10章 カルボプロストトロメタミン市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- カルボプロストトロメタミン産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Taj Pharmaceuticals Limited
    • Pfizer Inc.
    • Apionex Pharma Pvt Ltd.
    • MANUS AKTTEVA BIOPHARMA LLP
    • Biosynth
    • Monvi labs
    • Amneal Pharmaceuticals LLC
    • ChemScene
    • Bio-Techne
    • ANGUS Chemical Company
    • WATSON INTERNATIONAL LIMITED
    • SimSon Pharma Limited
    • Ryvis Pharma
    • Universal Biologicals
    • Woodward Pharma
    • Merck KGaA
    • Dr. Reddy's Laboratories Ltd.
    • BioSpectra Inc.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Carboprost Tromethamine Market: Product Formulation Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Formulation
  • TABLE Global Carboprost Tromethamine Market, by Product Formulation2018-2030 (USD Million)
  • TABLE Carboprost Tromethamine Market: ApplicationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Carboprost Tromethamine Market, by Application2018-2030 (USD Million)
  • TABLE Carboprost Tromethamine Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Carboprost Tromethamine Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Carboprost Tromethamine Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Carboprost Tromethamine Market, by Region 2018-2030 (USD Million)
  • TABLE North America Carboprost Tromethamine Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Carboprost Tromethamine Market, by Product Formulation, 2018-2030 (USD Million)
  • TABLE North America Carboprost Tromethamine Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Carboprost Tromethamine Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Carboprost Tromethamine Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Carboprost Tromethamine Market, by Product Formulation, 2018-2030 (USD Million)
  • TABLE EuropeCarboprost Tromethamine Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Carboprost Tromethamine Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Carboprost Tromethamine Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Carboprost Tromethamine Market, by Product Formulation, 2018-2030 (USD Million)
  • TABLE Asia Pacific Carboprost Tromethamine Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Carboprost Tromethamine Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Carboprost Tromethamine Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Carboprost Tromethamine Market, by Product Formulation, 2018-2030 (USD Million)
  • TABLE Latin America Carboprost Tromethamine Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Carboprost Tromethamine Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Carboprost Tromethamine Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Carboprost Tromethamine Market, by Product Formulation, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Carboprost Tromethamine Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Carboprost Tromethamine Market, by Distribution Channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE Carboprost Tromethamine Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Formulation segment market share analysis, 2022&2030
  • FIGURE Product Formulation segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022&2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2022&2030
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Carboprost Tromethamine Market share and leading players, 2022
  • FIGURE Europe Carboprost Tromethamine Market share and leading players, 2022
  • FIGURE Asia Pacific Carboprost Tromethamine Market share and leading players, 2022
  • FIGURE Latin America Carboprost Tromethamine Market share and leading players, 2022
  • FIGURE Middle East and Africa Carboprost Tromethamine Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Carboprost Tromethamine Market share analysis by country, 2022
  • FIGURE Germany Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Carboprost Tromethamine Market share analysis by country, 2022
  • FIGURE India Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Carboprost Tromethamine Market share analysis by country, 2022
  • FIGURE Brazil Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Carboprost Tromethamine Market share analysis by country, 2022
  • FIGURE Saudi Arabia Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Carboprost Tromethamine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1657

REPORT HIGHLIGHT

Carboprost tromethamine market size was valued at USD 1,509.6 Million in 2022, expanding at a CAGR of 4.3% from 2023 to 2030.

Carboprost tromethamine also referred to as hemabate, is a prostaglandin used to treat postpartum hemorrhage and severe bleeding post-child delivery in females. Additionally, it is utilized as a contraceptive pill to induce abortion by gradual expulsion of the placenta and causing uterine contractions. The drug is provided anytime between the third and fifth month of the pregnancy. Increased contractions are the result of it working on the F receptor or the E2 receptor sites present in the uterine muscles.

Carboprost Tromethamine Market - Market Dynamics:

  • The increasing prevalence of postpartum hemorrhage, government initiatives, and healthcare policies drives the market growth
  • Postpartum hemorrhage is excessive bleeding after childbirth is a major cause of maternal morbidity and mortality worldwide. The growing use of prevalence of postpartum hemorrhage (PPH) is increasing the demand for drugs such as carboprost tromethamine that help to control and manage postpartum bleeding. Additionally, due to the high birthrate, postpartum hemorrhage cases also rise. Thus the rising prevalence of PPH will boost the global carboprost tromethamine market growth. However, the lack of highly skilled healthcare professionals is a reason to hamper the market demand. Moreover, healthcare and government organizations are enabling several initiatives to improve maternal healthcare and minimize maternal mortality. In line with this, it involves programs that focus on managing postpartum hemorrhage effectively. As a result, the initiatives increase the demand for drugs such as carboprost tromethamine, which will drive carboprost tromethamine market growth.

Carboprost Tromethamine Market - Key Insights:

  • As per the analysis shared by our research analyst, the global carboprost tromethamine market is estimated to grow annually at a CAGR of around 4.3% over the forecast period (2023-2030)
  • The carboprost tromethamine industry is projected to grow at a significant rate due to the rise of high birthrate, postpartum hemorrhage cases
  • Based on product formulation segmentation, postpartum hemorrhage treatment was predicted to show maximum market share in the year 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Carboprost Tromethamine Market- Segmentation Analysis:

  • The global carboprost tromethamine market is segmented on the basis of product formulation, application, distribution channel, and region.
  • The market is divided into two categories based on product formulation: pregnancy abortion and postpartum hemorrhage treatment. The postpartum hemorrhage treatment segment is likely to maintain its dominance. The growth of the segment is attributed to the increasing prevalence of postpartum hemorrhage (PPH). Due to the increasing number of birth cases, there is also a rising incidence of postpartum hemorrhage.
  • The market is divided into two categories based on application: powder for reconstitution and injectable formulation. The injectable formulation segment is accounted to witness speedy growth in the market. The injectable formulations are commonly used in clinical settings for controlled dosage administration and their quick onset of action. Additionally, the injectable form is often employed in emergencies, like postpartum hemorrhage, where effective and rapid treatment is essential.
  • The market is divided into three categories based on distribution channels: online pharmacies, hospital pharmacies, and retail pharmacies. The hospital pharmacies segment is likely to possess the largest revenue share over the forecast period. Hospital pharmacies are an essential distribution channel for drugs like carboprost tromethamine. In addition, hospital pharmacies are likely to dispense and stock them as required, particularly in cases of postpartum hemorrhage or different medical issues requiring the use of this medication.

Carboprost Tromethamine Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Carboprost Tromethamine Market- Competitive Landscape:

Advances in the medical techniques and technology techniques for managing postpartum hemorrhage are expected to affect the market for medications like Carboprost Tromethamine. The market growth may also be influenced by other treatments or medications for similar indications. Moreover, major players are also adopting types of strategies such as collaboration, R&D activities, mergers & acquisitions, and partnerships. For instance, in February 2022, Amneal introduced that four generic injectables products are now approved. Moreover, azacitidine 100 mg, atropine sulfate injection, USP 0.5 mg/5 mL, carboprost tromethamine injection, USP 250 mcg/mL, and dexamethasone sodium phosphate injection, USP 10 mg/mL have received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA).

Recent Developments:

For instance, in March 2021, Sunny Pharmtech Inc. released a statement announcing that the US FDA approved its ANDA ("Abbreviated New Drug Application") of Carboprost Tromethamine Injection. Additionally, carboprost tromethamine Injection is indicated for aborting pregnancy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARBOPROST TROMETHAMINE MARKET KEY PLAYERS

  • Taj Pharmaceuticals Limited
  • Pfizer Inc.
  • Apionex Pharma Pvt Ltd.
  • MANUS AKTTEVA BIOPHARMA LLP
  • Biosynth
  • Monvi labs
  • Amneal Pharmaceuticals LLC
  • ChemScene
  • Bio-Techne
  • ANGUS Chemical Company
  • WATSON INTERNATIONAL LIMITED
  • SimSon Pharma Limited
  • Ryvis Pharma
  • Universal Biologicals
  • Woodward Pharma
  • Merck KGaA
  • Dr. Reddy's Laboratories Ltd.
  • BioSpectra Inc.

GLOBALCARBOPROST TROMETHAMINE MARKET, BY PRODUCT FORMULATION

  • Pregnancy Abortion
  • Postpartum Hemorrhage Treatment

GLOBAL CARBOPROST TROMETHAMINE MARKET, BY APPLICATION

  • Powder for Reconstitution
  • Injectable Formulation

GLOBAL CARBOPROST TROMETHAMINE MARKET, BY DISTRIBUTION CHANNEL

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies

GLOBAL CARBOPROST TROMETHAMINE MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
  • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Carboprost Tromethamine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Carboprost Tromethamine Market Snippet by Product Formulation
    • 2.1.2. Carboprost Tromethamine Market Snippet by Application
    • 2.1.3. Carboprost Tromethamine Market Snippet by Distribution Channel
    • 2.1.4. Carboprost Tromethamine Market Snippet by Country
    • 2.1.5. Carboprost Tromethamine Market Snippet by Region
  • 2.2. Competitive Insights

3. Carboprost Tromethamine Key Market Trends

  • 3.1. Carboprost Tromethamine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Carboprost Tromethamine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Carboprost Tromethamine Market Opportunities
  • 3.4. Carboprost Tromethamine Market Future Trends

4. Carboprost Tromethamine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Carboprost Tromethamine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Carboprost Tromethamine Market Landscape

  • 6.1. Carboprost Tromethamine Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Carboprost Tromethamine Market - By Product Formulation

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Formulation, 2022&2030 (%)
    • 7.1.2. Pregnancy Abortion
    • 7.1.3. Postpartum Hemorrhage Treatment

8. Carboprost Tromethamine Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Powder for Reconstitution
    • 8.1.3. Injectable Formulation

9. Carboprost Tromethamine Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022&2030 (%)
    • 9.1.2. Online Pharmacies
    • 9.1.3. Hospital Pharmacies
    • 9.1.4. Retail Pharmacies

10. Carboprost Tromethamine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Carboprost Tromethamine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Carboprost Tromethamine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Carboprost Tromethamine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Carboprost Tromethamine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Carboprost Tromethamine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Formulation, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Carboprost Tromethamine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Taj Pharmaceuticals Limited
    • 11.2.2. Pfizer Inc.
    • 11.2.3. Apionex Pharma Pvt Ltd.
    • 11.2.4. MANUS AKTTEVA BIOPHARMA LLP
    • 11.2.5. Biosynth
    • 11.2.6. Monvi labs
    • 11.2.7. Amneal Pharmaceuticals LLC
    • 11.2.8. ChemScene
    • 11.2.9. Bio-Techne
    • 11.2.10. ANGUS Chemical Company
    • 11.2.11. WATSON INTERNATIONAL LIMITED
    • 11.2.12. SimSon Pharma Limited
    • 11.2.13. Ryvis Pharma
    • 11.2.14. Universal Biologicals
    • 11.2.15. Woodward Pharma
    • 11.2.16. Merck KGaA
    • 11.2.17. Dr. Reddy's Laboratories Ltd.
    • 11.2.18. BioSpectra Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us